Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fennec Pharmaceuticals (FENC) Operating Leases (2023 - 2024)

Fennec Pharmaceuticals (FENC) has disclosed Operating Leases for 2 consecutive years, with $2000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Operating Leases changed N/A year-over-year to $2000.0, compared with a TTM value of $2000.0 through Dec 2024, changed N/A, and an annual FY2024 reading of $2000.0, changed N/A over the prior year.
  • Operating Leases was $2000.0 for Q4 2024 at Fennec Pharmaceuticals, down from $7000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $17000.0 in Q1 2024 and bottomed at $2000.0 in Q4 2024.